Phio Pharmaceuticals Corp. (PHIO)
0.808
+0.01
(+1.00%)
USD |
NASDAQ |
Nov 06, 10:36
Phio Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2019 | -10.09K% |
| December 31, 2018 | |
| September 30, 2018 | -2.62K% |
| June 30, 2018 | -3.28K% |
| March 31, 2018 | -9.73K% |
| December 31, 2017 | -13.35K% |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | -24.58K% |
| March 31, 2016 | -22.31K% |
| December 31, 2015 |
| Date | Value |
|---|---|
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | -8.66K% |
| December 31, 2014 | -16.46K% |
| September 30, 2014 | -13.79K% |
| June 30, 2014 | -16.72K% |
| March 31, 2014 | -7.88K% |
| December 31, 2013 | -8.65K% |
| September 30, 2013 | -2.24K% |
| June 30, 2013 | -871.6% |
| March 31, 2013 | -27.16K% |
| December 31, 2012 | -4.28K% |
| September 30, 2012 | -2.88K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CapForce, Inc. | 84.94% |
| Agenus, Inc. | -1.64% |
| Amgen, Inc. | 37.29% |
| Anika Therapeutics, Inc. | 10.15% |
| BioCryst Pharmaceuticals, Inc. | 21.03% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -93.31% |
| Return on Assets | -84.88% |
| Return on Invested Capital | -93.31% |
| Return on Net Operating Assets | -131.7K% |